Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9637933 | 0.79 | MAPT (0.36) | KDM4EALDH1A1CYP1A2MAPTALOX15 | |
| SCHEMBL10659842 | 0.79 | KDM4E (0.30) | KDM4EALDH1A1CYP1A2MAPTALOX15 | |
| SCHEMBL10661289 | 0.79 | KDM4E (0.30) | KDM4EALDH1A1CYP1A2MAPTALOX15 | |
| SCHEMBL1826724 | 0.79 | PTGDR2 (0.33) | KDM4EALDH1A1CYP1A2MAPTALOX15 | |
| SCHEMBL10657572 | 0.78 | — | — | |
| SCHEMBL10576170 | 0.78 | — | — | |
| SCHEMBL10658775 | 0.76 | KDM4E (0.32) | KDM4EALDH1A1CYP1A2MAPTALOX15 | |
| SCHEMBL10657582 | 0.76 | — | — | |
| SCHEMBL2065796 | 0.76 | PTGS2 (0.46) | KDM4EALDH1A1CYP1A2MAPTALOX15 | |
| SCHEMBL7771628 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150037069-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER AND IMAGE FORMING APPARATUS | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2015-02-05 | — | — | US | disclosed |
| US-20100197783-A1 | Radiation Protection Using Single Wall Carbon Nanotube Derivatives | DARPA | 2010-08-05 | — | — | US | disclosed |
| US-20100197783-A1 | Radiation Protection Using Single Wall Carbon Nanotube Derivatives | DARPA | 2010-08-05 | — | — | US | disclosed |
| US-20100197783-A1 | Radiation Protection Using Single Wall Carbon Nanotube Derivatives | DARPA | 2010-08-05 | — | — | US | disclosed |
| WO-2008118960-A2 | RADIATION PROTECTION USING CARBON NANOTUBE DERIVATIVES | WILLIAM MARSH RICE UNIVERSITY (US) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008118960-A2 | RADIATION PROTECTION USING CARBON NANOTUBE DERIVATIVES | WILLIAM MARSH RICE UNIVERSITY (US) | 2008-10-02 | — | — | WO | disclosed |
| US-4708966-A | SUBSTITUTED DI-TERT-BUTYL PHENOL DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1987-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197783-A1 | Radiation Protection Using Single Wall Carbon Nanotube Derivatives | POT1, MGMT, CTSA | KDM4E 4587/4885ALDH1A1 1246/4885CYP1A2 1796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.